Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.053 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.7 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |